gip and glp 1 receptor agonist New strategies for the treatment of obesity metabolic dysfunctions What is GLP-1 and Its
Description
July 23, 2024
Jos Manuel Carrascosa has participated as PI/SI and/or guest presenter and/or advisor for Almirall, Janssen, Abbvie, UCB, Boehringer-Ingelheim, Lilly, Novartis, Amgen, BMS, and Sandoz
Secondary outcomes included nonfatal MI, nonfatal stroke, HHF and renal composite outcome, defined in most trials as a composite of progression to end-stage renal disease or a sustained decrease of at least 40% in estimated glomerular filtration rate (eGFR)
Breast cancer risks increase as women age, particularly after menopause
Other Diabetes Medications: Metformin, SGLT2 inhibitors, and DPP-4 inhibitors may be suitable alternatives
But while Saxenda is used once daily, Wegovy is used once weekly
